120
Participants
Start Date
October 12, 2021
Primary Completion Date
March 21, 2023
Study Completion Date
March 21, 2023
Favipiravir
Oral Favipiravir 1800 mg twice daily on Day 1, followed by 400 mg four (4) times daily from Day 2 to Day 7
Nitazoxanide
Nitazoxanide at 1000 mg twice daily on Day 1 followed by 500 mg four (4) times daily from Day 2 to Day 7
Nitazoxanide Placebo
Nitazoxanide matched placebo at 1000 mg twice daily on Day 1 followed by 500 mg four (4) times daily from Day 2 to Day 7.
"Hospital de Infectología Daniel Méndez Hernández del Centro Médico Nacional La Raza", Mexico City
University College, London
OTHER
Centro de Investigacion y Estudios Avanzados del Instituto Politecnico Nacional (CINVESTAV)
UNKNOWN
Universidad Autonoma de Guadalajara
UNKNOWN
Siegfried Rhein S.A. de C.V.
UNKNOWN
Strides Pharma Science Limited
UNKNOWN
Hakken Enterprise
UNKNOWN
Coordinación de Investigación en Salud, Mexico
OTHER_GOV